{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:18:55Z","timestamp":1776784735607,"version":"3.51.2"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["XJZT24CZ14"],"award-info":[{"award-number":["XJZT24CZ14"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["XJZT24QN55"],"award-info":[{"award-number":["XJZT24QN55"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["LHJJ2024-YX21"],"award-info":[{"award-number":["LHJJ2024-YX21"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["LHJJ2024-YX03"],"award-info":[{"award-number":["LHJJ2024-YX03"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jep.2025.120737","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:43:17Z","timestamp":1760398997000},"page":"120737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PB","title":["Bioactive compounds and multitarget action mechanism of Erzhi pills in alleviating metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"355","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2317-2019","authenticated-orcid":false,"given":"Kai","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meina","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingru","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2025.120737_bib1","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.3390\/molecules26247629","article-title":"Carpachromene ameliorates insulin resistance in HepG2 cells via modulating IR\/IRS1\/PI3k\/Akt\/GSK3\/FoxO1 pathway","volume":"26","author":"Alaaeldin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jep.2025.120737_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.767314","article-title":"Current and potential therapies targeting inflammation in NASH","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jep.2025.120737_bib3","series-title":"Resmetirom's Approval: Highlighting the Need for Comprehensive Approaches in NASH Therapeutics","author":"Alshehade","year":"2024"},{"key":"10.1016\/j.jep.2025.120737_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jep.2025.120737_bib5","series-title":"Need-To-Know NAFLD","first-page":"146","article-title":"Anti-Inflammatory drugs: metabolic inflammation in NASH\u2014A drug target?","author":"Armandi","year":"2023"},{"key":"10.1016\/j.jep.2025.120737_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cld.2012.05.002","article-title":"Mechanisms of disease progression in NASH: new paradigms","volume":"16","author":"Bohinc","year":"2012","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jep.2025.120737_bib7","series-title":"Protective Effect of Active Ingredients Group in Liver Protection from Erzhi Pill on Hepatocyte Injury Induced by CCl4 or H2O2","author":"Cai XiuJiang","year":"2012"},{"key":"10.1016\/j.jep.2025.120737_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/ijms17091575","article-title":"Molecular pathogenesis of NASH","volume":"17","author":"Caligiuri","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2025.120737_bib9","series-title":"Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in high-fat diet-fed BALB\/C Mice","author":"Cao","year":"2016"},{"key":"10.1016\/j.jep.2025.120737_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"key":"10.1016\/j.jep.2025.120737_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/biom10091332","article-title":"Rescue of hepatic phospholipid remodeling defect in iPLA2\u03b2-null mice attenuates obese but not non-obese fatty liver","volume":"10","author":"Chamulitrat","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jep.2025.120737_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153964","article-title":"Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120737_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2025.120737_bib14","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jep.2025.120737_bib15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1097\/HEP.0000000000000326","article-title":"Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis","volume":"77","author":"Du","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2025.120737_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121793","article-title":"Salidroside alleviates acetaminophen-induced hepatotoxicity via Sirt1-mediated activation of Akt\/Nrf2 pathway and suppression of NF-\u03baB\/NLRP3 inflammasome axis","volume":"327","author":"Gao","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2025.120737_bib18","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.jmb.2015.04.015","article-title":"Crosstalk between Hippo and TGF\u03b2: subcellular localization of YAP\/TAZ\/Smad complexes","volume":"427","author":"Grannas","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jep.2025.120737_bib19","article-title":"Resmetirom: first approval","volume":"1\u20137","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.jep.2025.120737_bib20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/hep.31167","article-title":"Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis","volume":"72","author":"Kumar","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP\u2010activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib22","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the \u03b1 isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jep.2025.120737_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1\u03b1 transcription coactivator","volume":"447","author":"Li","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jep.2025.120737_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116625","article-title":"Salidroside promotes angiogenesis after cerebral ischemia in mice through Shh signaling pathway","volume":"174","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.120737_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155285","article-title":"Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway","volume":"124","author":"Liao","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120737_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00210-020-01914-1","article-title":"Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin\/CMKLR1 signalling pathway and Treg\/Th17 ratio","volume":"394","author":"Lu","year":"2021","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.jep.2025.120737_bib27","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1158\/0008-5472.CAN-21-4390","article-title":"Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non\u2013cell autonomous liver carcinogenesis","volume":"82","author":"Makino","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.jep.2025.120737_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib29","first-page":"297","article-title":"Salidroside alleviates LPS-induced liver injury and inflammation through SIRT1-NF-\u03baB pathway and NLRP3 inflammasome","volume":"27","author":"Meng","year":"2024","journal-title":"Iranian journal of basic medical sciences"},{"key":"10.1016\/j.jep.2025.120737_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","article-title":"Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine","volume":"20","author":"Moya","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jep.2025.120737_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/ijms23010498","article-title":"Non-alcoholic steatohepatitis (NASH) and organokines: what is now and what will be in the future","volume":"23","author":"Santos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2025.120737_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.120737_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.120737_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104636","article-title":"4, 5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses","volume":"152","author":"Sheng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2025.120737_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12967-023-04380-4","article-title":"Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase","volume":"21","author":"Shi","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jep.2025.120737_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153846","article-title":"TMT-based proteomics analysis reveals the protective effect of Jueyin granules on imiquimod-induced psoriasis mouse model by causing autophagy","volume":"96","author":"Song","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120737_bib37","volume":"2007","author":"Stienstra","year":"2007"},{"key":"10.1016\/j.jep.2025.120737_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cld.2009.07.003","article-title":"Apoptosis and cytokines in non-alcoholic steatohepatitis","volume":"13","author":"Syn","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jep.2025.120737_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2025.120737_bib40","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jep.2025.120737_bib41","article-title":"A critical role for the NLRP3 inflammasome in NASH","volume":"14","author":"Thomas","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.120737_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 inflammasome in the progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2025.115335","article-title":"Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2\/AMPK-mediated pyroptotic inhibition","volume":"199","author":"Wang","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jep.2025.120737_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jep.2025.120737_bib46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.120737_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116908","article-title":"A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPAR\u03b1 signaling pathway","volume":"176","author":"Xie","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.120737_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115331","article-title":"Salidroside ameliorates acetaminophen-induced acute liver injury through the inhibition of endoplasmic reticulum stress-mediated ferroptosis by activating the AMPK\/SIRT1 pathway","volume":"262","author":"Xu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jep.2025.120737_bib49","first-page":"1303","article-title":"Experimental study of active ingredients group in liver protection from Erzhi Wan on acute hepatic injury induced by CCl4 in mice","volume":"37","author":"Yan","year":"2012","journal-title":"Zhongguo Zhong yao za zhi= Zhongguo Zhongyao Zazhi= China Journal of Chinese Materia Medica"},{"key":"10.1016\/j.jep.2025.120737_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154466","article-title":"TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP\/Notch3 pathway","volume":"107","author":"Yang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120737_bib51","first-page":"145","article-title":"Protective effect of different polar fraction of Erzhi Pill on alcoholic liver injury","volume":"20","author":"Ying","year":"2014","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.jep.2025.120737_bib52","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120737_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/rej.2024.0053","article-title":"Wedelolactone attenuates liver fibrosis and hepatic stellate cell activation by suppressing the hippo pathway","volume":"27","author":"Zhang","year":"2024","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.jep.2025.120737_bib54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.apsb.2019.10.008","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2025.120737_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153270","article-title":"The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism","volume":"77","author":"Zhao","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120737_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154721","article-title":"Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: an update","volume":"113","author":"Zheng","year":"2023","journal-title":"Phytomedicine"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125014291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125014291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:34:09Z","timestamp":1764041649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125014291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"alternative-id":["S0378874125014291"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.120737","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactive compounds and multitarget action mechanism of Erzhi pills in alleviating metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.120737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120737"}}